S&P Keeps Buy on J&J

Plus analysts' opinions on Boston Scientific, Computer Associates, and more

Johnson & Johnson (JNJ ): Keeps 4 STARS (buy)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.